NanoViricides: Big Things In a Small Package
During an interview with OneMedPlace, President and Chairman of NanoViricides (NNVC) Anil Diwan summed up the influenza treatment market in just a few words: It is like trying to hit a moving target.
flu
For Vax Providers, Flu Season Off to a Running Start
It’s flu season again, and more than 690,000 people in the U.S. have already been vaccinated, reports healthcare analytics service SDI.
As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181
DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.
GSK and Enigma Pair Up to Develop Influenza Diagnostics
The new test would analyze swab samples and return a diagnosis in less than 60 minutes.